Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04869319 · ClinicalTrials.gov registry record
Electronic Triggers: Messaging After A1C EHR Alert
A clinical trial of Hemoglobin S and Diagnostic Tests, sponsored by NYU Langone Health.
- Completed
- Registry status
- 2,403
- Enrollment target
- 1
- Study location
NCT04869319: Completed study of Hemoglobin S and Diagnostic Tests, sponsored by NYU Langone Health.
NCT04869319 is a study of Hemoglobin S and Diagnostic Tests that has completed, run by NYU Langone Health. The registered enrollment target is 2,403 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04869319, a study of Hemoglobin S and Diagnostic Tests, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 2,403 participants
- Enrollment target
- 1
- Study location
Study Summary
Studying subjects with HbA1C tests \>10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.
Primary Outcome
This outcome measures the rate at which participants complete an A1C test within 3 months of the message intervention being sent and 9 months of their original test.
Conditions Studied
Interventions
- BEHAVIORAL MyChart message
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,403 participants |
| Start Date | 2020-07-13 |
| Est. Completion | 2024-03-28 |
What the finished NCT04869319 record still lists
NCT04869319 is an observational study that tracks outcomes without assigning an intervention. Its 2,403 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Hemoglobin S appearing as the primary indexed condition, and to 1 intervention - of which MyChart message is the first listed.
NCT04869319 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04869319 about?
NCT04869319 is a clinical study titled "Electronic Triggers: Messaging After A1C EHR Alert". Studying subjects with HbA1C tests \>10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.
What is the current status of trial NCT04869319?
This trial is currently completed. The enrollment target is 2,403 participants. The study started on 2020-07-13. Estimated completion is 2024-03-28.
What conditions does trial NCT04869319 study?
This clinical trial studies the following conditions: Hemoglobin S, Diagnostic Tests.
What interventions are being tested in trial NCT04869319?
The interventions under investigation include: MyChart message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04869319?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04869319 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemoglobin S
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI